(13R)-S-cysteinyl-(14S)-hydroxy-(4Z,7Z,9E,11E,16Z,19Z)-docosahexaenoic acid

Term ID

CHEBI:138209

Synonyms

(4Z,7Z,9E,11E,13R,14S,16Z,19Z)-13-{[(2R)-2-amino-2-carboxyethyl]sulfanyl}-14-hydroxydocosa-4,7,9,11,16,19-hexaenoic acid
MCTR3

Definition

A docosanoid that is (14S)-hydroxy-(4Z,7Z,9E,11E,16Z,19Z)-docosahexaenoic acid in which a cysteinyl group is attached at position 13R via a sulfide linkage.

References

PMID:26881986
PMID:27791009
Reaxys:28337235

Ontology

ChEBI ( EBI )

Relationships

is a type of: dicarboxylic acid docosanoid organic sulfide S-substituted L-cysteine secondary alcohol

dicarboxylic acid docosanoid organic sulfide S-substituted L-cysteine secondary alcohol Show first 5 Terms
has_role: human metabolite

human metabolite Show first 5 Terms
inverse is_conjugate_base_of: (13R)-S-cysteinyl-(14S)-hydroxy-(4Z,7Z,9E,11E,16Z,19Z)-docosahexaenoate(1-)

(13R)-S-cysteinyl-(14S)-hydroxy-(4Z,7Z,9E,11E,16Z,19Z)-docosahexaenoate(1-) Show first 5 Terms
is_conjugate_acid_of: (13R)-S-cysteinyl-(14S)-hydroxy-(4Z,7Z,9E,11E,16Z,19Z)-docosahexaenoate(1-)

(13R)-S-cysteinyl-(14S)-hydroxy-(4Z,7Z,9E,11E,16Z,19Z)-docosahexaenoate(1-) Show first 5 Terms

Phenotype

Phenotype resulting from (13R)-S-cysteinyl-(14S)-hydroxy-(4Z,7Z,9E,11E,16Z,19Z)-docosahexaenoic acid

Phenotype where environments contain (13R)-S-cysteinyl-(14S)-hydroxy-(4Z,7Z,9E,11E,16Z,19Z)-docosahexaenoic acid

Phenotype modified by environments containing (13R)-S-cysteinyl-(14S)-hydroxy-(4Z,7Z,9E,11E,16Z,19Z)-docosahexaenoic acid

Human Disease Model